Results 41 to 50 of about 7,343 (255)

Surface chemistry of heterobimetallic Ge-M (M = Mo, W) complexes in zeolite Y. [PDF]

open access: yes, 1991
The intrazeolite chemistry of the two germylene complexes Cl2CTHF)GeM(CO)5 (M = Mo, W) was studied with x-ray absorption spectroscopy (Ge, Mo, W edge EXAFS) and in-situ FTIR/TPD-MS techniques.
Bein, Thomas   +2 more
core   +1 more source

Severe congestive heart failure in elderly patient with Paget’s disease

open access: yesGeriatric Care, 2017
Paget’s disease of bone is characterized by focal areas of increased bone turnover, affecting one or several bones throughout the skeleton. Paget’s disease is often asymptomatic, but can be associated with bone pain and other skeletal and non-skeletal ...
Lorenzo Palleschi, Eleonora Nunziata
doaj   +1 more source

Rhenium Radioisotopes for Medicine, a Focus on Production and Applications

open access: yesMolecules, 2022
In recent decades, the use of alpha; pure beta; or beta/gamma emitters in oncology, endocrinology, and interventional cardiology rheumatology, has proved to be an important alternative to the most common therapeutic regimens. Among radionuclides used for
Licia Uccelli   +9 more
doaj   +1 more source

Inhibitory effect of salmon calcitonin on bone resorption: morphological study of the tibial growth plate in rats. [PDF]

open access: yes, 1993
Salmon calcitonin (sCT) at doses of 100 and 50 UI given subcutaneously to growing rats produced in vivo evidence of osteoclastic activity inhibition. Histological assessment was carried out by measuring the perichondrial ring of Lacroix height, and a ...
Coci A.   +3 more
core   +1 more source

PROFILAKTIKA NARUPENI OBMENA KAL'TsIYa I SISTEM EGO REGULYaTsII PRI DLITEL'NOY GIPOKINEZII S UChASTIEM ChELOVEKA

open access: yesОстеопороз и остеопатии, 2007
In conditions of 120-daily bedrest changes of a metabolism of the calcium, the functions of a bone directed on preservation at a necessary level of a bone material at the maximal economy level in these conditions were studied.
O I ORLOV
doaj   +1 more source

Calcitonin in the treatment of Paget’s disease of bone [PDF]

open access: yes, 1989
A retrospective survey at the request of Pharmacy & Therapeutics Committee, St. Luke’s Hospital was undertaken to evaluate prescribing habits of calcitonin in Paget’s disease of bone, as well as to assess its effectiveness.peer ...
Mallia, Carmel
core  

Pamidronato dissódico (APD) no tratamento das metástases ósseas.

open access: yesActa Médica Portuguesa, 1993
Diphosphonates are potent inhibitors of bone resorption, they have been evaluated in several clinical trials for bone metastases. We performed a clinical study to evaluate the therapeutic effect of Disodium Pamidronate over pain and radiologic evolution ...
L Costa, C Moreira, E B da Costa
doaj   +1 more source

Diphosphonates in the treatment of osteoporosis

open access: yesCleveland Clinic Journal of Medicine, 1990
Etidronate disodium has been shown to increase bone density and decrease fracture rates, but it may have more important applications in the prevention of bone loss.
openaire   +3 more sources

Challenges and Opportunities in the Use of Iron Photosensitizers for Dye‐Sensitized Solar Cells and Photoelectrosynthetic Cells Applications

open access: yesEcoEnergy, EarlyView.
This review gathers examples of iron‐based photosensitizers that have been successfully immobilized on metal oxide surfaces for dye‐sensitized solar cells and potential dye‐sensitized photoelectrosynthesic cells applications. A critical comparison of Fe‐based photosensitizers is made based on their photophysical properties, electrochemistry, and ...
Lakshmi Narayan Satheesh   +3 more
wiley   +1 more source

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

open access: yesBMC Musculoskeletal Disorders, 2022
Background Both denosumab and bisphosphonates have been demonstrated effective for glucocorticoid-induced osteoporosis. However, evidence-based medicine is still lacking to prove the clinical results between denosumab and bisphosphonates.
Lianghai Jiang   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy